How do you translate ClinicalTrials.gov outcome tables and adverse-event results correctly? Preserve each study’s NCT identifier, posted-result status, prespecified outcome definition, time frame, arm or comparison group, participant denominator, unit of measure, statistical estimate and safety-event category. People searching for clinical trial result translation, ClinicalTrials.gov results interpretation, primary outcome table translation, serious adverse event reporting, number affected versus number of events, or multilingual research summaries need a disciplined source-to-target method. The words must convey what the registered result actually reports, not a more persuasive interpretation.
A registry result can look simple: a treatment group has one number and a comparison group has another. Yet the meaning depends on who was analysed, which participants were at risk, what was measured, when it was measured, how missing observations were handled and whether the entry is a prespecified outcome, a post hoc analysis or a reported adverse event. A fluent translation that says ‘the treatment worked’ or ‘the medicine caused’ without evidence may distort the study more than an obvious vocabulary mistake. This guide teaches translation and responsible reading of public study data; it is not a clinical interpretation of any particular treatment or a recommendation for patients.
The ClinicalTrials.gov Study Basics definitions separate primary outcome measures, secondary outcome measures, adverse events, serious adverse events and registry status. The U.S. National Library of Medicine’s record-display guidance explains how study fields and posted results appear, while its quality-control notice distinguishes results submissions under review from posted records. These references are better starting points than a generic synonym dictionary when translating technical result labels.
The short answer: preserve the reporting contract
Translate the human-language explanations, but treat the result record as a contract of evidence. Identify the study record and its version; distinguish registration or protocol information from posted summary results; copy each outcome’s title, definition, time frame and analysis population into a review sheet; keep every unit, arm, denominator and uncertainty statement attached to its number; separately handle participant flow, baseline characteristics, outcome results, statistical comparisons and adverse-event sections. After drafting, run a numeric and causal-language audit with a reader who understands trial reporting.
The main canonical boundary is important. The existing eduKateSG article on clinical trial protocols, informed consent and case report forms explains how to translate a study’s planned methods and participant-facing or data-collection documents. This new guide owns the later, different job of translating reported registry result tables and their evidence states. A protocol plans what will be measured; a posted result reports what was analysed and summarised. A faithful article does not treat these as one document.
The visible problem: the same numbers can tell different stories
Consider a synthetic two-arm study with 120 people randomised to each arm but only 110 and 108 included in a particular analysis. Suppose a reported event affected 12 of 110 participants in one arm and 8 of 108 in the other. A hurried translation reports ’12 events versus 8 events among 120 patients in each group’. The numerator may have represented people affected, not separate event occurrences, and the denominator may have been the participants at risk rather than all randomised people. The summary could be mathematically neat and evidentially wrong.
Now imagine the editor writes that the difference was caused by the assigned intervention, even though the registry’s adverse-event table labels an event without demonstrating causality. Or a target-language translation says ‘serious disease’ where the source uses ‘serious adverse event’, a category defined by particular outcomes. Or it converts a prespecified primary outcome into a casual observation while dropping the assessment time. Each change alters what readers can infer. A serious translator must separate statistical association, adverse-event reporting, and evidence of causation.
This is why this article uses a three-layer discipline. The first layer is raw record identity: exact NCT ID, archive or update status and field names. The second is table structure: arms, measures, time frames, counts, units, analysis populations and summary statistics. The third is interpretation: what the source actually concludes, what it does not conclude, and whether confidence or limitations were stated. Translation moves across languages only after those layers are understood.
First principles: how a registry result acquires meaning
1. An NCT identifier is a stable record identity
ClinicalTrials.gov records use an NCT number. Treat it as an exact identifier linking the public registry entry and its history, not an abbreviation that may be translated into an ordinary phrase.
Wrong interpretation: A wrong digit can direct a reader to a different study, making otherwise accurate text untraceable. Verification: Copy the identifier character by character and test its link. Keep it with the study title and version reference.
2. Registration, submission and posting differ
A study may be registered, results may be submitted, the submission may be in quality-control review, and results may be posted. These states should not be collapsed into a generic ‘results published’ label.
Wrong interpretation: Calling a submitted but unposted results package ‘peer-reviewed evidence’ invents both a publication status and a quality guarantee. Verification: Record the registry’s actual state and relevant dates. The NLM describes special displays for results still undergoing QC.
3. A protocol outcome is a plan, not necessarily a reported result
Registered primary and secondary outcomes specify planned measurements. A results table shows what was submitted for a measure and may include amendments or deviations documented in the record.
Wrong interpretation: Translating a protocol’s outcome description as though it were the study’s finding confuses intention with observation. Verification: Separate ‘the study intended to measure’ from ‘the submitted results show’, and consult the study’s history for relevant changes.
4. Primary and secondary describe prespecified roles
A primary outcome measure is designated as especially important for evaluating the intervention; a secondary measure has another specified role. The label does not itself tell the reader whether an effect is large, significant or clinically meaningful.
Wrong interpretation: Rendering ‘primary outcome’ as ‘best result’ or ‘first successful result’ inserts a value judgement absent from the term. Verification: Use consistent target-language regulatory or research terms, preserving measure title, unit, assessment period and analytic status.
5. An outcome title without a time frame is incomplete
A measure such as change in a symptom score may be assessed at baseline, week 4, week 12 or another defined point. The same word ‘change’ can refer to different calculations and populations.
Wrong interpretation: An editor who drops ‘at week 12’ may turn a time-bound result into an apparent permanent effect. Verification: Keep the time frame as part of the measure identity; check baseline and follow-up definitions separately.
6. Participant flow is not outcome population
Numbers randomised, started, completed, withdrawn, exposed, analysed or included in an outcome table can differ. A trial’s participant-flow section is not a universal denominator for every other result.
Wrong interpretation: Replacing each outcome’s N with the enrollment count creates false event rates and misleading precision. Verification: Copy the denominator from the relevant result or safety table and identify the population used for that analysis.
7. Arm and comparison group names must stay linked
Registry tables organise values by group. A label can refer to randomised treatment, dose, sequence, comparator, control or another study-specific grouping. Renaming groups casually can erase what was compared.
Wrong interpretation: If a ‘standard care’ arm is translated as ‘no treatment’, the description can become false even before any statistics are discussed. Verification: Match every number to the original group heading and retain a controlled glossary of arms, treatments and periods.
8. Counts of affected participants differ from numbers of events
One participant may experience multiple adverse-event occurrences. Many safety tables separately report number affected, number at risk and number of events. These are related but not identical quantities.
Wrong interpretation: A target caption calling ’15 events’ ’15 patients’ may overstate the number of people affected; the reverse mistake can understate event occurrences. Verification: Read column headers and table notes; never infer a denominator from a numerator or equate participants and occurrences.
9. Serious is a defined event category, not a synonym for severe
ClinicalTrials.gov defines serious adverse events by outcomes such as death, life-threatening circumstances, certain hospitalisations, disability or congenital anomalies, with important medical-event considerations. Severity grades use another dimension.
Wrong interpretation: Translating ‘serious adverse event’ as ‘very painful side effect’ changes both definition and potential attribution. Verification: Use official event definitions and preserve the distinction between seriousness, severity, expectedness and causality.
10. An adverse event is not automatically caused by treatment
An adverse event occurs during or after a defined period in a study and may or may not be caused by the intervention. The registry definition expressly warns against assuming attribution.
Wrong interpretation: ‘Ten participants suffered drug-caused injury’ is unsupported when the source reports adverse events without causal attribution. Verification: Write ‘reported adverse events’ or another faithful source term, and express causality only when the record or cited analysis supports it.
11. An event-reporting threshold is a selection rule
Other non-serious adverse-event tables may use a stated frequency threshold to decide which event types appear. An unlisted event is not necessarily proof that it never occurred.
Wrong interpretation: ‘No other adverse events occurred’ can be a false statement when the source only displays categories above a threshold. Verification: Preserve the table’s threshold and any note on assessment method; do not interpret omissions as measured zeros.
12. Outcomes require their units and scale directions
An outcome may be a count of participants, mean score, median time, change from baseline, rate or proportion. On a particular scale, higher could mean better or worse. A target phrase like ‘improved’ needs evidence of the direction.
Wrong interpretation: A lower score can be an improvement on one scale and a deterioration on another. Verification: Retain the full measure definition and avoid describing direction as benefit unless the scale and analysis justify it.
13. Measures of uncertainty are not decorative
Confidence intervals, standard deviations, interquartile ranges, statistical-test outputs and missing-data notes answer different questions. A translation should neither erase them nor present them as synonyms.
Wrong interpretation: Calling a confidence interval ‘the range all participants fell within’ gives the wrong statistical interpretation. Verification: Use established target statistical terms and keep each estimate with its correct precision measure.
14. A p-value is not a treatment-effect size
If a statistical analysis reports a p-value, it does not quantify the magnitude of benefit or prove clinical importance. A text that moves from one statistical field to broad therapeutic claims changes the research.
Wrong interpretation: ‘Significant’ in statistical prose cannot be assumed to mean medically large, certain or safe. Verification: Translate the author’s stated statistical conclusion without adding an unsupported patient-facing recommendation.
15. The time frame of safety collection matters
Safety tables specify periods of observation and collection practices. Events in a 14-day window are not directly comparable with events collected across a much longer period without contextual analysis.
Wrong interpretation: ‘Only two adverse events’ omits who was followed, for how long and how they were assessed. Verification: Carry the collection window and assessment description with event counts; state known differences rather than smoothing them away.
16. Blank, not reported and zero are different states
A registry field can be absent, not provided, not applicable, under review, or reported as zero. Those states should remain distinct, especially in a multilingual table.
Wrong interpretation: Replacing a blank with zero supplies data that the source did not provide. Replacing zero with ‘no data’ discards an observation. Verification: Use explicit missing-data wording and preserve the actual state shown by the source.
17. Registry history can modify interpretation
Study record histories may show changes to measure descriptions, outcome status or submissions. A target-language article that quotes an old version must not silently merge it with current tables.
Wrong interpretation: Readers may not know that the described protocol or submitted result belonged to a previous version. Verification: Cite the version or access date and keep source links. Audit any comparison of archived versions as a separate exercise.
18. Public summary and scientific conclusion are different products
A lay translation can explain technical fields but should not manufacture conclusions from an unreviewed table. Patient relevance, risk-benefit assessment and external validity require interpretation beyond word translation.
Wrong interpretation: An enthusiastic summary can claim a treatment works for everyone although the source only reports results for a studied population. Verification: Explain the scope of the registry evidence and direct clinical decisions to qualified professionals and original clinical information.
A nine-pass translation method for registry results
Pass 1: Locate the correct study and date
Save the NCT ID, record URL, history or version context and result-posting status. Confirm that the data are from the intended study and that the result tab exists.
Quality outcome: A study title can change or be abbreviated; the exact identifier and version anchor the translation. Record which reviewer checked this field group. If an original definition is unclear, escalate it rather than quietly drafting around the ambiguity.
Pass 2: Separate protocol fields from result fields
Create sections for registration information, participant flow, baseline characteristics, outcome measures, statistical analyses, all-cause mortality and adverse events, as applicable.
Quality outcome: This prevents a planned measure from being reported as an observed result and stops safety-event summaries from being merged into efficacy conclusions. Record which reviewer checked this field group. If an original definition is unclear, escalate it rather than quietly drafting around the ambiguity.
Pass 3: Build an arm-and-population dictionary
List each group name, intervention or comparator description, period, population definition and source denominator. Keep abbreviations with their expanded meaning when the source defines them.
Quality outcome: The same trial can have different analysis sets across outcomes, so one global N value is not enough. Record which reviewer checked this field group. If an original definition is unclear, escalate it rather than quietly drafting around the ambiguity.
Pass 4: Create a measure inventory
For every outcome, copy measure title, description, time frame, unit, summary type, direction of scale and any analysis population note. Mark primary, secondary, other prespecified or post hoc where recorded.
Quality outcome: This inventory makes field omissions visible and supports a precise summary rather than a vague claim that ‘outcomes improved’. Record which reviewer checked this field group. If an original definition is unclear, escalate it rather than quietly drafting around the ambiguity.
Pass 5: Reconstruct the number relationships
For a table that gives affected and at-risk participants, identify both counts and confirm any displayed percentages. Distinguish counts of people, event occurrences, rates and point estimates.
Quality outcome: A numerical review is necessary because a translated number can be accurate while its label or denominator is wrong. Record which reviewer checked this field group. If an original definition is unclear, escalate it rather than quietly drafting around the ambiguity.
Pass 6: Preserve status and uncertainty
Mark not posted, results submitted, QC not complete, revised, estimated, missing and statistically uncertain where applicable. Carry source caveats into the target text.
Quality outcome: Even a clean table does not automatically justify a definitive treatment-effect statement. Record which reviewer checked this field group. If an original definition is unclear, escalate it rather than quietly drafting around the ambiguity.
Pass 7: Translate terms using domain conventions
Use authoritative language for adverse events, serious adverse events, primary outcomes, arms, analysis populations and confidence intervals. If the target lacks a direct term, explain its definition rather than inventing a misleading synonym.
Quality outcome: Professional term choice must serve evidence; consistency alone is insufficient if a term is wrongly defined. Record which reviewer checked this field group. If an original definition is unclear, escalate it rather than quietly drafting around the ambiguity.
Pass 8: Review layout and cross-references
Check column headers, row labels, footnotes, superscripts, group ordering, time frames and links between a summary and the underlying result record.
Quality outcome: A two-column layout error can swap treatment groups while leaving all numerical values unchanged. Record which reviewer checked this field group. If an original definition is unclear, escalate it rather than quietly drafting around the ambiguity.
Pass 9: Publish an auditable educational explanation
Link to the exact registry record or official generic definitions, label synthetic calculations as exercises and avoid patient advice. Include a small table or checklist that lets others reconstruct the meaning.
Quality outcome: A transparent source boundary is more valuable than a confident conclusion not supported by the registry data. Record which reviewer checked this field group. If an original definition is unclear, escalate it rather than quietly drafting around the ambiguity.
Worked examples: where interpretation changes after a small wording edit
Every example below is hypothetical; counts and names are invented solely to teach source fidelity. They make no claim about a real intervention, treatment benefit or risk.
Worked example 1: People affected versus event occurrences
Synthetic source situation: One group has 12 participants affected and 18 event occurrences, with 110 participants at risk.
Faithful rendering: A faithful translation distinguishes ’12 of 110 participants were affected’ from ’18 events were recorded’. The affected-person proportion would be approximately 10.9% if that is the reported calculation.
Tempting error: ’18 of 110 people experienced an event’ incorrectly turns occurrences into people. ‘The drug injured 18 people’ additionally assumes causality. Transfer lesson: This is the most useful basic self-check for adverse-event tables: read the header and denominator before translating the noun after the number.
Worked example 2: Different denominators for different analyses
Synthetic source situation: A study randomised 120 per arm; a particular outcome table analyses 110 and 108.
Faithful rendering: A correct summary says that the outcome table used the stated analysis populations. It can separately mention randomisation counts if relevant but does not merge them.
Tempting error: ‘Each group had 120 people in the efficacy analysis’ invents a fact by copying the randomisation total. Transfer lesson: Keep a denominator alongside each measure, even when this makes the paragraph slightly longer.
Worked example 3: Primary outcome versus secondary outcome
Synthetic source situation: An entry labels one measure primary at week 12 and a second measure secondary at week 24.
Faithful rendering: A faithful explanation preserves rank, content and assessment time for both measures without assuming the first was successful or the second unimportant.
Tempting error: ‘The main success was measured at week 12 and the less reliable result at week 24’ invents success and reliability. Transfer lesson: Primary and secondary are design roles, not translated adjectives for good and bad.
Worked example 4: Adverse event versus adverse reaction
Synthetic source situation: A registry result reports a headache adverse event during observation without a statement that treatment caused it.
Faithful rendering: The correct sentence describes a reported adverse event in the specified group and window. Causal language is withheld unless independently supported by the study.
Tempting error: ‘The drug caused headaches’ may be a stronger claim than a reported safety table permits. Transfer lesson: Keep event occurrence, causal attribution and group assignment as distinct propositions.
Worked example 5: Serious does not mean intense
Synthetic source situation: A source labels a hospitalisation event as serious but does not grade symptom severity in the example.
Faithful rendering: Explain that seriousness is a defined reporting category and that symptom intensity is a separate dimension not specified here.
Tempting error: ‘The participant experienced extremely severe symptoms’ guesses intensity from category membership. Transfer lesson: The target-language term should reflect the reporting definition, not everyday emotional force.
Worked example 6: Measure direction matters
Synthetic source situation: A hypothetical outcome scale runs from 0 to 100, with lower scores representing fewer symptoms.
Faithful rendering: A decrease of 8 points can be described as a lower symptom score under this defined scale. Whether that constitutes clinically meaningful benefit is a different question.
Tempting error: ‘The patient’s condition worsened by eight points’ reverses the defined direction. Transfer lesson: Check each scale’s direction, unit and population; a universal rule such as ‘higher is always better’ is unreliable.
Worked example 7: Time frames cannot be swapped
Synthetic source situation: A study reports change from baseline to week 6; another figure presents measurement at week 12.
Faithful rendering: The correct summary attaches each result to the source’s own assessment time rather than combining them into one ‘after treatment’ snapshot.
Tempting error: ‘The benefit lasted 12 weeks’ may be unsupported if week 12 was merely a separate measurement. Transfer lesson: Dates and intervals are part of the study’s questions, not optional timeline decoration.
Worked example 8: Missing value versus zero event
Synthetic source situation: The source presents an empty field because information was not provided; another study has a recorded zero in a table.
Faithful rendering: The first should be described as unreported or absent as appropriate; the second as a zero result under its specified collection rule.
Tempting error: ‘No events occurred’ cannot be inferred from the empty field, and ‘not measured’ cannot replace a reported zero. Transfer lesson: Preserve missingness and absence as different evidence states.
Worked example 9: A frequency reporting threshold
Synthetic source situation: An adverse-event table lists categories over a defined threshold for other events.
Faithful rendering: A faithful translation says the displayed categories meet the chosen reporting rule, not that every possible event type is included.
Tempting error: ‘These were the only side effects’ mistakes a filtered display for a complete account. Transfer lesson: Always bring the threshold into a reader summary when omission could change the reader’s inference.
Worked example 10: Results submitted versus results posted
Synthetic source situation: An archive version shows results submitted and QC review pending, while another version shows posted results.
Faithful rendering: Explain the record status with its date and do not call the earlier submission a final posted registry result.
Tempting error: ‘Officially verified conclusions’ is not warranted simply because a submission appears in a registry workflow. Transfer lesson: Status wording should preserve the actual process rather than replace it with praise or dismissal.
Worked example 11: Descriptive difference versus causal conclusion
Synthetic source situation: Two groups report different observed mean changes without enough contextual information here to establish a clinical claim.
Faithful rendering: A correct translation describes the reported comparison and, where available, its statistical estimate and limitations. It does not promise an individual patient outcome.
Tempting error: ‘The treatment will cure the condition’ goes far beyond a summary result table. Transfer lesson: Translation must carry the source’s evidential scope rather than extrapolate across people or settings.
Failure modes: quick error diagnosis before publication
Failure 1: Adding causality where there is an adverse-event count
The article says an intervention caused an event although the source states only that an event occurred. Correction: Use occurrence language and reserve causal attribution for explicit, supported evidence. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 2: Turning seriousness into severity
A defined reporting category becomes a statement about the intensity of symptoms. Correction: Check official seriousness definitions separately from scale-based severity grading. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 3: Swapping arm columns
A target-language table reorders names but not numerical values. Correction: Freeze arm IDs and check each column header against every translated row. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 4: Borrowing the wrong denominator
An event rate uses total enrollment rather than the at-risk count. Correction: Copy denominator and analysis population directly from the table carrying the numerator. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 5: Confusing participants and event occurrences
A total event count becomes a number of people. Correction: Mark ‘affected’, ‘at risk’ and ‘events’ as controlled, different nouns. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 6: Reading a non-posted result as a completed publication
A submission in QC is described as a definitive posted result. Correction: Verify registry status and history; do not infer peer-review quality. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 7: Erasing the outcome assessment time
A week-12 finding becomes a timeless general claim. Correction: Keep exact time frame in the measure label, table and summary. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 8: Confusing primary importance with successful outcome
The term primary is translated as main success or best result. Correction: Use the trial-design term without predicting a positive finding. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 9: Ignoring the analysis population note
Different measures share one invented N across the document. Correction: Keep population and missingness notes per outcome. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 10: Using materiality-style language without a statistic
A numerical difference becomes ‘clinically significant’ without supporting criteria. Correction: Distinguish statistical significance, effect size and clinical relevance, and report only claims in source. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 11: Dropping frequency thresholds
The target calls a filtered safety table exhaustive. Correction: Preserve reporting thresholds and event-collection methods. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 12: Changing a confidence interval into participant range
The target says all individuals fell between the interval endpoints. Correction: Use appropriate statistical terminology and retain the estimate’s actual interpretation. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 13: Hiding a historical correction
A study result is quoted after an update without showing the version. Correction: Add archive or access context and re-check changed fields against the cited version. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Failure 14: Giving treatment advice from a translation exercise
A classroom example tells patients to start, stop or adjust medication. Correction: Remove clinical recommendations; refer the reader to professionals and official clinical information. In the final review, highlight the source field and the target sentence together. If the target contains an additional claim about effectiveness, harm, certainty, population or time, verify it explicitly or remove it.
Practice tasks: become accurate with new records
Practice 1: Make an NCT traceability card
Choose a publicly accessible registry study record; write the NCT ID, study title, result posting status, version or access date and a link. Do not interpret its treatment findings yet.
Model self-check: Your card passes when another reader can locate the exact study and determine whether the cited result content is posted.
Practice 2: Build an outcome-field table
Select one outcome and copy its exact title, role, time frame, unit, analysis population and summary type into separate cells. Translate only after the fields are visible.
Model self-check: A faithful paragraph should allow someone to rebuild the same measure identity without guessing which week or scale was used.
Practice 3: Audit a synthetic participant flow
Write invented but consistent counts for randomised, started, completed and analysed participants. Translate a short result summary that never calls all of these counts enrollment.
Model self-check: Mark the different population states in distinct words so a reader knows which denominator belongs to which table.
Practice 4: Compute an illustrative affected proportion
From a synthetic 12 affected out of 110 at risk, calculate 12 ÷ 110 × 100 ≈ 10.9%. Record people affected separately from 18 total occurrences.
Model self-check: A safe result names numerator, denominator and type. It does not attach causality or claim an event rate per person-time unless those data exist.
Practice 5: Preserve a reporting threshold
Write an adverse-event caption that explicitly says categories below a stated frequency threshold may not appear in that table.
Model self-check: Ask whether a second reader could mistake the displayed categories for an exhaustive list. Repair any wording that suggests missing categories never occurred.
Practice 6: Correct serious versus severe
Draft two sentences: one that faithfully calls an event serious under a defined reporting rule and another that invents the intensity of a symptom. Explain the difference.
Model self-check: The lesson should identify distinct concepts and avoid assuming that every severe symptom meets seriousness criteria, or vice versa.
Practice 7: Convert a registry status without exaggeration
Write a target-language statement for ‘results submitted; review not concluded’ and one for ‘results posted’. Use no value judgements.
Model self-check: Both statements should preserve record status; neither should imply that an independent clinical expert endorsed the interpretation.
Practice 8: Run a denominator blind review
Hide the source and ask a partner to identify exactly which N was used for each result in your target-language summary. Then reveal the source table.
Model self-check: If the partner cannot reconstruct the populations, simplify the text by making denominators and arm labels explicit.
Practice 9: Transfer to another evidence domain
Take the same method to a public-health surveillance line list or a camera-trap detection table and distinguish cases, events, subjects or detections.
Model self-check: The general method is to preserve unit of analysis, population, time frame, missingness and certainty before explaining the results.
Frequently asked questions about registry result translation
Is a ClinicalTrials.gov record the same as a scientific journal article?
No. A trial registry record and posted summary results have their own fields, reporting status and history. A peer-reviewed paper may add analyses and interpretation, and the two should be cross-checked rather than treated as identical evidence products.
What is a primary outcome measure?
It is a planned measure considered of greatest importance for evaluating the intervention or study question. Its label does not mean that the result was positive. Preserve its definition, assessment time, unit, analysis population and role in the target text.
Does ‘adverse event’ mean a treatment caused harm?
Not automatically. ClinicalTrials.gov defines an adverse event as an unfavourable health change during or within a defined period after study participation that may or may not be caused by the intervention. Causal interpretation requires more evidence.
What is the difference between serious and severe?
Seriousness refers to defined consequences or medically important event criteria; severity refers to intensity or grading. A highly uncomfortable symptom may not meet seriousness criteria, and a serious event need not be described by an intensity adjective.
Should I translate counts of people as counts of events?
No. One participant can have multiple occurrences. Copy and translate affected participants, at-risk participants and event occurrences separately; maintain the exact denominator and reporting group for each statistic.
Why do study groups sometimes have different Ns in separate tables?
Enrollment, randomisation, exposure, safety populations and individual outcome-analysis populations may differ. Missing observations and analysis rules can also affect denominators. Each number must be interpreted in its table’s own context.
Does a reported zero mean no data were collected?
No. Zero is a reported numerical value, while an empty field, not applicable status or no reported results mean different things. Preserve those distinct states and consult the field notes.
How should I translate time-to-event measures?
Keep the event definition, starting point, censoring or follow-up context when stated, statistical summary and time unit. A median time cannot be freely paraphrased as a guaranteed date for every individual.
Is a p-value proof of treatment benefit?
No. It is a statistical quantity interpreted in a test framework, not the size of benefit or a promise of clinical significance. Translate only the actual statistical conclusion and accompanying uncertainty.
Do posted registry results equal medical advice?
No. Study results describe a particular research design and population. Individual medical decisions require qualified assessment, current clinical guidance and patient-specific circumstances.
Can AI help translate ClinicalTrials.gov tables?
It can extract labels, suggest terminology and compare numbers, but it can also invent causal explanations or confuse denominators. A professional review should verify each arm, measure, time and safety term against the original record.
How should a translator handle historical record changes?
Save the NCT ID, archive or version context, access date and specific result posting state. When a field was amended, label the old and new versions rather than merging them into one narrative.
What is the best first learning exercise?
Take a short, public result table and reconstruct its field map without interpreting treatment value: outcome name, time frame, arm labels, unit, numerators, denominators and uncertainty. Only then attempt a readable translation.
Where does this guide sit in the translation library?
This article is limited to published registry outcome and adverse-event result evidence. Use the existing clinical protocol and informed-consent guide for planned study procedures, and the wider translation and vocabulary hubs for methods and terminology.
References, connected owners and the next learning route
For protocol design and source paperwork, continue to clinical trial protocols, informed consent and case report forms. For a different public-health evidence type, see surveillance case definitions, outbreak line lists and epidemiology dashboards. The two articles serve distinct canonical jobs: a registry result table is not a surveillance case record, and a planned protocol is not a posted results section.
The general method continues at Master Art of Translation, the series index, the Vocabulary Learning Hub and How English Works. Reference authorities include ClinicalTrials.gov Study Basics, its policy and data-definition links, and the NLM registry-display explanation. They should be consulted alongside a particular study record when accurate interpretation is necessary.
Final principle: the right target-language sentence does not merely repeat a number. It preserves which participants were measured, which outcome or event the count describes, which group and time frame it belongs to, what uncertainty and review status apply, and which claims the study does not establish. Translate the evidence, not a promotional conclusion.